Puma Biotechnology, Inc. (PBYI)
5.70
-1.90
(-25.00%)
USD |
NASDAQ |
Feb 27, 16:00
5.69
-0.01
(-0.18%)
After-Hours: 20:00
Puma Biotechnology Research and Development Expense (TTM) : 62.07M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| Pfizer Inc. | 10.25B |
| Rigel Pharmaceuticals, Inc. | 28.24M |
| CorMedix, Inc. | 12.46M |
| BioXcel Therapeutics, Inc. | 28.55M |